TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), ...
The Manila Times

Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...
AHA/ASA Journals

Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis

Background: Patients with a transient ischemic attack (TIA) or minor stroke have an increased risk of subsequent stroke that persists for at least 10 years. We aimed to identify prognostic factors ...
Psychology Today

Young/Middle-Aged Drug Users Risk Stroke

Young adults may suffer strokes when using cocaine, meth, and even cannabis, and the onset may be shortly after drug use and is directly linked to these drugs.
Endocrinology Advisor

AACE Releases 2026 Update to Type 2 Diabetes Management Algorithm

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.
The Cardiology Advisor

Signs, Symptoms, and Management of Traumatic Brain Injury vs Stroke

Stroke and traumatic brain injury (TBI) symptoms and signs vary. TBI includes light, noise sensitivity; stroke presents with facial drooping.

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

TONMYA (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to ...